Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9453239
APP PUB NO 20080193483A1
SERIAL NO

11574285

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides modified vaccinia Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTE OF HEALTHOFFICE OF TECHNOLOGY TRANSFER SUITE 325 6011 EXECUTIVE BOULEVARD ROCKVILLE MD 20852-3804

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Moss, Bernard Bethesda, US 51 625
Robinson, Harriet L Atlanta, US 19 261
Wyatt, Linda Rockville, US 8 73

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00